Sufentanil Citrate Patent Expiration

1. Dsuvia patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10245228 VERTICAL PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Jan, 2027

(2 years from now)

US10507180 VERTICAL PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Jan, 2027

(2 years from now)

US8535714 VERTICAL PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Jan, 2027

(2 years from now)

US8778394 VERTICAL PHARMS Small-volume oral transmucosal dosage forms
Jan, 2027

(2 years from now)

US10342762 VERTICAL PHARMS Small-volume oral transmucosal dosage forms
Jan, 2027

(2 years from now)

US8252328 VERTICAL PHARMS Bioadhesive drug formulations for oral transmucosal delivery
Jan, 2027

(2 years from now)

US8231900 VERTICAL PHARMS Small-volume oral transmucosal dosage
Jan, 2027

(2 years from now)

US8778393 VERTICAL PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Jan, 2027

(2 years from now)

US9320710 VERTICAL PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Jan, 2027

(2 years from now)

US8226978 VERTICAL PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Jan, 2027

(2 years from now)

US8865211 VERTICAL PHARMS Bioadhesive drug formulations for oral transmucosal delivery
Jan, 2027

(2 years from now)

US9744129 VERTICAL PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Jan, 2027

(2 years from now)

US8252329 VERTICAL PHARMS Bioadhesive drug formulations for oral transmucosal delivery
Jan, 2027

(2 years from now)

US11676691 VERTICAL PHARMS Storage and dispensing devices for administration of oral transmucosal dosage forms
Mar, 2030

(5 years from now)

US10896751 VERTICAL PHARMS Storage and dispensing devices for administration of oral transmucosal dosage forms
Mar, 2030

(5 years from now)

US8574189 VERTICAL PHARMS Storage and dispensing devices for administration of oral transmucosal dosage forms
Mar, 2030

(5 years from now)

US8865743 VERTICAL PHARMS Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Oct, 2030

(6 years from now)

US8202535 VERTICAL PHARMS Small-volume oral transmucosal dosage forms
Oct, 2030

(6 years from now)

US8945592 VERTICAL PHARMS Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
Jul, 2031

(7 years from now)

US11672738 VERTICAL PHARMS Apparatus and methods for dispensing oral transmucosal dosage forms
Feb, 2038

(13 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Nov 02, 2021

Market Authorisation Date: 02 November, 2018

Treatment: Treatment of acute pain

Dosage: TABLET

More Information on Dosage

DSUVIA family patents

Family Patents